![Bayer United States of America - Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes Bayer United States of America - Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes](http://s24.q4cdn.com/107164196/files/doc_multimedia/Photo_for_press_release_use-(002).jpg)
Bayer United States of America - Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
![Bayer's Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chief | Fierce Pharma Bayer's Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chief | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1636471145/bayer-office-building-socialmedia-1200x630.jpg/bayer-office-building-socialmedia-1200x630.jpg?VersionId=aA.fg6OClE.y58YpZLPaSCPK95cS6acv)
Bayer's Kerendia/SGLT2 combo exceeds expectations, with more expansion ahead: pharma chief | Fierce Pharma
![Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, type 2 diabetes Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, type 2 diabetes](https://medicaldialogues.in/h-upload/2022/10/15/1500x900_188053-bayer-new-1.jpg)
Bayer Kerendia granted expanded indication in EU for broad range of patients with chronic kidney disease, type 2 diabetes
![Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes | Business Wire Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes | Business Wire](https://mms.businesswire.com/media/20210709005441/en/890434/22/Photo_for_press_release_use+%28002%29.jpg)
Bayer's KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes | Business Wire
![Le premier médicament de Bayer, Kerendia (finérénone) a des bienfaits rénaux et cardiovasculaires chez un large éventail de patients ! - Nouvelles de l'industrie - Nouvelles - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd Le premier médicament de Bayer, Kerendia (finérénone) a des bienfaits rénaux et cardiovasculaires chez un large éventail de patients ! - Nouvelles de l'industrie - Nouvelles - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](http://fr.hspchem.com/Content/uploads/2021524038/2021091717063368b262f74869417dada4b31506edfc26.png)
Le premier médicament de Bayer, Kerendia (finérénone) a des bienfaits rénaux et cardiovasculaires chez un large éventail de patients ! - Nouvelles de l'industrie - Nouvelles - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Bayer's Kerendia (finerenone) Receives NICE Recommendation for Chronic Kidney Disease Associated with Type 2 Diabetes Bayer's Kerendia (finerenone) Receives NICE Recommendation for Chronic Kidney Disease Associated with Type 2 Diabetes](https://www.pharmashots.com/public/images/20220715135603_ogImage_50.jpg)